Martin Andreánsky

1.8k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Martin Andreánsky is a scholar working on Hematology, Virology and Molecular Biology. According to data from OpenAlex, Martin Andreánsky has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Martin Andreánsky's work include HIV Research and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Myeloid Leukemia Research (3 papers). Martin Andreánsky is often cited by papers focused on HIV Research and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Acute Myeloid Leukemia Research (3 papers). Martin Andreánsky collaborates with scholars based in United States, Czechia and Canada. Martin Andreánsky's co-authors include Dario Campana, C‐H Pui, Chihaya Imai, I. Nicholson, Terrence L. Geiger, Keichiro Mihara, Raul C. Ribeiro, Jeffrey E. Rubnitz, Bassem I. Razzouk and Elaine Coustan‐Smith and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and Blood.

In The Last Decade

Martin Andreánsky

19 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia

2004 643 citations Chihaya Imai, Keichiro Mihara et al. Leukemia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Andreánsky United States	11	654	287	265	239	203	21	1.0k
Victoria Shi United States	12	671 1.0×	323 1.1×	341 1.3×	159 0.7×	174 0.9×	23	1.1k
Holly M. Horton United States	20	591 0.9×	668 2.3×	836 3.2×	222 0.9×	116 0.6×	48	1.8k
Kenneth Micklethwaite Australia	23	1.0k 1.5×	431 1.5×	280 1.1×	468 2.0×	141 0.7×	61	1.6k
Angel Varela‐Rohena United States	9	1.1k 1.7×	835 2.9×	381 1.4×	395 1.7×	251 1.2×	12	1.6k
Catherine De Greef Belgium	17	268 0.4×	438 1.5×	415 1.6×	161 0.7×	68 0.3×	21	1.0k
Wenbo Yu Australia	17	507 0.8×	340 1.2×	293 1.1×	190 0.8×	177 0.9×	31	941
Hossam A. Abdelsamed United States	13	625 1.0×	749 2.6×	417 1.6×	106 0.4×	82 0.4×	30	1.2k
Gwendolyn Binder-Scholl United States	7	761 1.2×	340 1.2×	1.1k 4.0×	658 2.8×	174 0.9×	11	1.7k
Joyce Chen United States	9	924 1.4×	1.0k 3.5×	610 2.3×	328 1.4×	270 1.3×	20	2.0k
Amy N. Courtney United States	19	1.1k 1.6×	1.0k 3.5×	322 1.2×	254 1.1×	218 1.1×	38	1.7k

Countries citing papers authored by Martin Andreánsky

Since Specialization

Citations

This map shows the geographic impact of Martin Andreánsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Andreánsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Andreánsky more than expected).

Fields of papers citing papers by Martin Andreánsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Andreánsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Andreánsky. The network helps show where Martin Andreánsky may publish in the future.

Co-authorship network of co-authors of Martin Andreánsky

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Andreánsky. A scholar is included among the top collaborators of Martin Andreánsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Andreánsky. Martin Andreánsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2025). Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation and Cellular Therapy. 31(10). 826.e1–826.e10. 1 indexed citations

Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2021). Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplantation and Cellular Therapy. 28(3). 174.e1–174.e5. 3 indexed citations

Líška, Dávid & Martin Andreánsky. (2021). Medial tibial stress syndrome. 28(1). 32–36.

Shah, Niketa C., Allistair Abraham, Eric Anderson, et al.. (2020). Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated Following Allogeneic Transplantation in Patients with Sickle Cell Disease. Blood. 136(Supplement 1). 33–33. 1 indexed citations

Andreánsky, Martin, et al.. (2015). Intra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory. Pediatric Blood & Cancer. 62(12). 2226–2228. 2 indexed citations

Lund, Troy C., Sara Cathey, Weston P. Miller, et al.. (2014). Outcomes after Hematopoietic Stem Cell Transplantation for Children with I-Cell Disease. Biology of Blood and Marrow Transplantation. 20(11). 1847–1851. 24 indexed citations

Rumlová, Michaela, Martin Andreánsky, Michael Sakalian, et al.. (2008). The impact of altered polyprotein ratios on the assembly and infectivity of Mason-Pfizer monkey virus. Virology. 384(1). 59–68. 5 indexed citations

Graham, Melanie L., et al.. (2008). 236: Busulfan and Single-Dose Melphalan as Preparative Therapy for Infants and Young Children Undergoing Stem Cell Transplantation for Leukemia: A Single Center Experience. Biology of Blood and Marrow Transplantation. 14(2). 87–88. 1 indexed citations

Andreánsky, Martin, Roger Fiederlein, & Michael L. Graham. (2006). Busulfan and melphalan as preparative therapy for stem cell transplantation in pediatric patients with acute myelogenous leukemia (AML) and myelodysplasia (MDS). Biology of Blood and Marrow Transplantation. 12(2). 85–85. 1 indexed citations

10.

Miyairi, Isao, et al.. (2005). Acute Necrotizing Ulcerative Gingivitis and Bacteremia Caused by Stenotrophomonas maltophilia in an Immunocompromised Host. The Pediatric Infectious Disease Journal. 24(2). 181–183. 20 indexed citations

11.

Coustan‐Smith, Elaine, Amar Gajjar, Nobuko Hijiya, et al.. (2004). Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse. Leukemia. 18(3). 499–504. 93 indexed citations

12.

Imai, Chihaya, Keichiro Mihara, Martin Andreánsky, et al.. (2004). Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia. Leukemia. 18(4). 676–684. 643 indexed citations breakdown →

13.

Coustan‐Smith, Elaine, Raul C. Ribeiro, Jeffrey E. Rubnitz, et al.. (2003). Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia. British Journal of Haematology. 123(2). 243–252. 94 indexed citations

14.

Andreánsky, Martin, Olga Hrušková‐Heidingsfeldová, Vladimı́r Havlı́ček, et al.. (1998). Three Active Forms of Aspartic Proteinase from Mason–Pfizer Monkey Virus. Virology. 245(2). 250–256. 28 indexed citations

15.

Pichová, Iva, et al.. (1998). Analysis of Autoprocessing of Mason-Pfizer Monkey Virus Proteinase in Vitro. Advances in experimental medicine and biology. 436. 105–108. 4 indexed citations

16.

Hrušková‐Heidingsfeldová, Olga, Martin Andreánsky, Milan Fábry, et al.. (1995). Cloning, Bacterial Expression, and Characterization of the Mason-Pfizer Monkey Virus Proteinase. Journal of Biological Chemistry. 270(25). 15053–15058. 33 indexed citations

17.

Majer, Pavel, et al.. (1993). Specificity Mapping of HIV-1 Protease by Reduced Bond Inhibitors. Archives of Biochemistry and Biophysics. 304(1). 1–8. 19 indexed citations

18.

Urban, Ján, Jan Konvalinka, Pavel Majer, et al.. (1992). Reduced‐bond tight‐binding inhibitors of HIV‐1 protease Fine tuning of the enzyme subsite specificity. FEBS Letters. 298(1). 9–13. 29 indexed citations

19.

Konvalinka, Jan, Martin Andreánsky, Iva Pichová, et al.. (1992). An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.. The EMBO Journal. 11(3). 1141–1144. 23 indexed citations

20.

Andreánsky, Martin, Olga Hrušková‐Heidingsfeldová, Jan Konvalinka, et al.. (1991). High‐level expression of enzymatically active bovine leukemia virus proteinase in E. coli. FEBS Letters. 287(1-2). 129–132. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact